Xiaobing Jiang

947 citations
41 papers · 672 indexed · h-index 18
Topics
Glioma Diagnosis and Treatment (11 papers)Immunotherapy and Immune Responses (11 papers)CAR-T cell therapy research (9 papers)

In The Last Decade

Xiaobing Jiang

38 papers receiving 666 citations

Peers

Xiaobing Jiang
Comparison fields: 5 of 74
  • Molecular Biology 264
  • Immunology 238
  • Oncology 213
  • Cancer Research 148
  • Genetics 120
Replace Daria S. Chulpanova with:
Daria S. Chulpanova Russia
Richard L. Price United States
Μαρκέλλα Ζαννίκου United States
Inti Peredo Sweden
Esther D. Kers‐Rebel Netherlands
Martine St-Jean Canada
Melinda N. Tea Australia
Mahmoud S. Alghamri United States
Diahnn Futalan United States
Herbert R. Lamche Austria
Xiaobing Jiang relative to Daria S. Chulpanova Russia Daria S. Chulpanova's profile →
Citations per field
00.5×1.5×
Daria S. Chulpanova · 1×
Citations per year

Countries citing papers authored by Xiaobing Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Jiang more than expected).

Fields of papers citing papers by Xiaobing Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Jiang. The network helps show where Xiaobing Jiang may publish in the future.

Co-authorship network of co-authors of Xiaobing Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Jiang. A scholar is included among the top collaborators of Xiaobing Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Jiang. Xiaobing Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 23
5 31
6 11
7 4
8 13
9 33
10 28
11 4
12 37
13 5
14 23
15 32
16 27
17 3
18 36
19 26
20 5

About Xiaobing Jiang

Xiaobing Jiang is a scholar working on Genetics, Immunology and Cancer Research, having authored 41 papers that have together received 672 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Genetics (120 citations), Immunology (238 citations) and Cancer Research (148 citations). Xiaobing Jiang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoling Lü, Hongyang Zhao, Fangcheng Zhang, Ruen Liu, Yujie Zhou, Dongdong Xiao, Xing Huang, Hongyang Zhao, Xuan Wang and Zhiyong Xiong. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026